Virtu Financial LLC Sells 20,340 Shares of Aptevo Therapeutics Inc. (NASDAQ:APVO)

Virtu Financial LLC cut its holdings in shares of Aptevo Therapeutics Inc. (NASDAQ:APVO) by 48.5% during the 4th quarter, Holdings Channel.com reports. The firm owned 21,627 shares of the biotechnology company’s stock after selling 20,340 shares during the quarter. Virtu Financial LLC’s holdings in Aptevo Therapeutics were worth $93,000 as of its most recent filing with the Securities & Exchange Commission.

Aptevo Therapeutics Stock Down 10.4 %

Aptevo Therapeutics stock opened at $1.12 on Monday. Aptevo Therapeutics Inc. has a one year low of $1.12 and a one year high of $180.19. The business has a fifty day moving average price of $3.32 and a 200-day moving average price of $135.88.

Analyst Upgrades and Downgrades

Separately, StockNews.com raised shares of Aptevo Therapeutics to a “sell” rating in a research report on Saturday, March 15th.

Aptevo Therapeutics Company Profile

Aptevo Therapeutics Inc, a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. It develops its products using ADAPTIR and ADAPTIR-FLEX platforms to generate monospecific, bispecific, and multi-specific antibody candidates capable of enhancing the human immune system against cancer cells.